Personnel Moves Archives - Page 30 of 42

Acutus Medical announces ‘ reduction in force’ amid restructuring

Acutus Medical (NSDQ:AFIB) announced today that it has undertaken a corporate restructuring that includes cutting some of its staff.

Part of the restructuring includes a planned reduction in force (RIF) for the developer of technologies for diagnosing and treating cardiac arrhythmias. A spokesperson for the company confirmed that Acutus is not disclosing the number of notified employees, but the company noted that the action is subject to the WARN Act, meaning it involves more than 50 people.

“We have undertaken a detailed review of our strategic priorities, the external environment, and cost structure and are restructuring the Company to sharpen our focus and strengthen our financial position,” Acutus President & CEO Vince Burgess said in a news release. “While challenging, this restructuring is a critical step in positioning Acutus for the future, and we are committed to treating impacted employees with respect and support through this period of change.”<…

Former Bardy Diagnostics CEO assumes corner office at Augmedics

Augmedics announced that it appointed former Bardy Diagnostics CEO Kevin Hykes as its new president & CEO.

Hykes, a 30-year medical device veteran, previously served as an operating partner at Revival Healthcare Capital. Before that, he was president & CEO at Bardy Diagnostics, having held the same roles at Relievant Medsystems before that.

Additionally, Hykes has been an operating partner at Versant Ventures and chairman & CEO at Metavention. Before Metavention, he was president & CEO of Cameron Health, which was bought by Boston Scientific in 2012.

The appointment of Hykes follows the September hiring of 28-year industry veteran Raj Asarpota as CFO of the company, which develops the xvision system for augmented reality-based surgical guidance.

“I am thrilled to welcome a commercial CEO of Kevin’s caliber,” Augmedics Founder Nissan Elimelech, who will stay with the company as chief product officer, said in a news release. “Our abi…

Getinge appoints three new executives

Getinge announced that it appointed three new executives, including a new president of its business for the North America region.

Gothenburg, Sweden-based Getinge confirmed that Patricia Fitch will succeed Eric Honroth as president of the North America region. Honroth has been appointed as president of life science at Getinge.

Additionally, Elin Frostehav, who had been serving as VP of critical care within the acute care therapies business, has been appointed as president of acute care therapies.

Fitch holds more than 30 years of medical device experience, having served in leadership roles in sales, marketing and operations at companies including Johnson & Johnson, Abiomed, St. Jude Medical and 3M.

Honroth joined Getinge in 2018 and has more than 20 years of experience in medical device leadership, with previous positions held at BD, CareFusion and Abbott. He succeeds Harald Castler, who is retiring.

Frostehav joined Getinge in 2019, ha…

Covalon appoints interim CFO

Covalon Technologies (TSXV:COV) announced today that it appointed Jason F. Gorel as its interim chief financial officer.

Mississauga, Ontario-based Covalon said in a news release that Gorel will assume the role as the company undertakes the search for a new CFO to assist with the next phase of growth.

Gorel has more than 20 years of experience in senior financial leadership roles, both in the private and public sectors, Covalon said. He has held the role of CFO at several companies, including Toronto Community Housing Corporation and BCS Global Networks.

He also held senior finance positions with SmartCentres Real Estate Investment Trust and Canadian Apartment Properties Real Estate Investment Trust. Gorel also serves on the board of directors at Fairplay Ventures and has served on the board at the Hearing Foundation of Canada.

“Jason brings financial leadership skills, operational experience, and knowledge of asset management and informatio…

Sanara MedTech appoints new CEO

Sanara MedTech (NSDQ:SMTI) announced today that it appointed Zachary B. Fleming as its new CEO, effective Jan. 1, 2022.

Fort Worth, Texas-based Sanara, formerly known as Wound Management Technologies, develops wound and skincare products for the wound care and surgical tissue repair markets.

“I am proud of what our team has accomplished to date for all of our stakeholders, including the patients, doctors, and clinicians who use our products,” Fleming said in a news release. “I am looking forward to the opportunity to lead the Sanara MedTech team, and to continue to work with Ron and the entire Sanara MedTech board to execute our strategy. Together, we will work to expand our surgical product offering, implement Sanara’s comprehensive wound and skin strategy, and fulfill our mission of providing products and technologies that offer a value-based solution while improving outcomes for wound patients.”

Fleming joined the company as its VP of sale…

Spectrum Plastics CEO is leaving to take over Natus Medical

Natus Medical’s incoming CEO Thomas Sullivan [Image from LinkedIn]

Natus Medical recently announced that it appointed Thomas Sullivan as president and CEO, effective December 27.

Sullivan previously served as president and CEO of medical device global contract manufacturer Spectrum Plastics. He has also held numerous leadership roles at A&E Medical, Symmetry Surgical and Symmetry Medical. In addition, he held executive positions at Johnson & Johnson, including president of J&J’s medical products Canada division and its U.S. orthopedics division.

Get the full story on MDO’s sister site MassDevice.

Natus Medical appoints new president and CEO

Natus Medical recently announced that it appointed Thomas Sullivan as president and CEO, effective Dec. 27.

Sullivan previously served as president and CEO of medical device global contract manufacturer Spectrum Plastics. He has also held numerous leadership roles at A&E Medical, Symmetry Surgical and Symmetry Medical. He held executive positions at Johnson & Johnson including president of J&J’s medical products Canaada division and its U.S. orthopedics division.

“We are thrilled to have Tom assume the leadership of Natus at this exciting time for our Company. He is a proven business leader with a long track record of success at creating shareholder value. As a Natus Independent Director these past three years, he has shown his strategic insight and drive for Natus’ potential for market leadership through holistic business model execution,” chairperson of the board Joshua Levine said in a news release. “The Board would like to thank Jonathan K…

12 of medtech’s biggest personnel changes in 2021

As medtech companies continued to drive innovation throughout the past 12 months, a number of high-level executives led the way.

Some of those companies and those executives opted for major changes over the course of 2021, though, with some high-profile moves from medtech giant to medtech giant.

Here are some of the biggest personnel moves in the medtech space in 2021:

Get the full story at our sister site, Medical Design & Outsourcing.

Medtronic makes changes to its executive committee

Medtronic (NYSE:MDT) announced today that it made changes to its executive committee as two senior figures confirmed their retirement.

General Counsel & Secretary Brad Lerman and CMO & CSO Dr. Rick Kuntz both plan to retire in 2022. Lerman will retire at the end of January and Kuntz intends to retire in April upon the conclusion of Medtronic’s fiscal year.

According to a news release, both Lerman and Kutz will retire in line with the company’s mandatory executive officer retirement age of 65 years old.

Ivan Fong will succeed Lerman at the end of January, assuming the official title of EVP, General Counsel & Secretary for Medtronic.

Fong joins Medtronic from 3M, having served as the St. Paul, Minnesota-based company’s Chief Legal & Policy Officer & Secretary. Previous roles include General Counsel for the U.S. Dept. of Homeland Security and Chief Legal Officer & Secretary for Cardinal Health. He will offici…

Bigfoot Biomedical announces trio of new senior hires

[Image from Bigfoot Biomedical]Bigfoot Biomedical announced today that it appointed three senior hires with experience in the diabetes and healthcare sectors.

Milpitas, California-based Bigfoot hired Matthew Clemente as SVP of Development, Robin A. Beadle as VP of Marketing and Scott Snead as VP of National Accounts. All three positions are newly created.

Get the full story at our sister site, Drug Delivery Business News.

Cordis names new CFO

Cordis today announced that it has appointed Christopher Scully as chief financial officer.

Scully will be responsible for leading the interventional cardiovascular technology company’s financial and IT functions to accelerate Cordis’s growth.

Prior to joining the company, Scully was executive VP and CFO for PPD. He played a role in the company’s IPO and its eventual sale to Thermo Fisher Scientific for an enterprise value greater than $20 billion.

“At Cordis, we are building a platform for medical device innovation that is possible only by tapping into the experience and insight of leaders like Chris Scully,” Cordis CEO Shar Matin said in a news release. “His record of achievement reflects his acumen and proficiency in developing long-term growth strategies that produce exceptional results.”

Scully also held numerous leadership roles at Pfizer, including chief commercial officer for its essential health b…

Alfred E. Mann Foundation brings former Alcon, Siemens Healthineers execs into C-suite

The Alfred E. Mann Foundation for Scientific Research (AMF) today confirmed the appointment of two new senior executives.

Los Angeles-based AMF appointed Charles Nelson as its new COO and Corey Dishmon as its chief legal officer/chief business officer.

Get the full story at our sister site, Drug Delivery Business News.